Synonyms: compound 7x [PMID: 24417566] | ON-123300 | ON123300
Compound class:
Synthetic organic
Comment: The chemical structure for narazaciclib was revealed in WHO proposed INN list 126 (Jan 2022), in which it was described as an cyclin dependent kinase (CDK) inhibitor and antineoplastic agent. We matched the structure to Onconova Therapeutics' clinical candidate ON123300 via PubChem. This compound was reported as a CDK4 and AMPK-related kinase 5 (ARK5 a.k.a. NUAK family kinase 1; NUAK1) inhibitor in 2014 [1]. It is being administered orally in clinical trial.
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Classification ![]() |
|
Compound class | Synthetic organic |
International Nonproprietary Names ![]() |
|
INN number | INN |
12004 | narazaciclib |
Synonyms ![]() |
compound 7x [PMID: 24417566] | ON-123300 | ON123300 |
Database Links ![]() |
|
BindingDB Ligand | 50447512 |
ChEMBL Ligand | CHEMBL3115681 |
GtoPdb PubChem SID | 461663435 |
PubChem CID | 56649281 |
Search Google for chemical match using the InChIKey | VADOZMZXXRBXNY-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | VADOZMZXXRBXNY |
Search PubMed clinical trials | narazaciclib |
Search PubMed titles | narazaciclib |
Search PubMed titles/abstracts | narazaciclib |
UniChem Compound Search for chemical match using the InChIKey | VADOZMZXXRBXNY-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | VADOZMZXXRBXNY-UHFFFAOYSA-N |